Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Nessa Carey will lead the strategic development and implementation of the Entrepreneur in Residence (EiR) programme in Medical Sciences, laying the foundation of a world-class innovation support ecosystem capable of accelerating the translation of world-leading research into innovative therapies, business and commercial products.

Dr Nessa Carey and Royal Society (logo)

Managed by the MSD Translational Research Office (TRO), the scheme is designed to provide Oxford's research community with access to world-leading expertise and advice across multiple industry sectors in the following themes:

  • Development of compelling translational project/technology strategies
  • Navigating hurdles associated with commercialisation and spin-out, working alongside Oxford University Innovation
  • Sourcing and development of high quality bids for external funding streams

Dr Nessa Carey will bring broad, multi-stakeholder and non-sector specific strategic oversight to the programme. With experience of the biotechnology industry landscape, she has vast knowledge of business, IP and commercialisation strategies across biomedical modalities, and will work with Oxford's academic community to enrich innovative translational programmes with commercial context.

Dr Carey will also work with our Business Partnerships Office and Translational Research Office teams, as well as Oxford University Innovation, to facilitate the recruitment of ‘Experts’ with an in-depth sector-specific knowledge, which they will apply to research programmes to ensure routes to translation are optimised and potential hurdles identified early.

Find out more about the Entrepreneur in Residence scheme and Dr Nessa Carey

About the Royal Society Entrepreneur in Residence (EiR) Scheme

The Royal Society Entrepreneur in Residence (EiR) scheme, part of the Science, Industry and Translation programme, aims to increase the knowledge and awareness in UK universities of cutting edge industrial science, research and innovation. The successful applicants are funded to spend 20% of their time over two years with their host university and collaborators, sharing their experiences to help mentor and support students and academics. The scheme has now funded 49 placements in 29 universities across the UK since its inception in 2018.

Read more on the Royal Society website.

 

Similar stories

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).

How artificial intelligence is shaping medical imaging

Dr Qiang Zhang of the Radcliffe Department of Medicine explains how artificial intelligence is being used to help researchers and physicians interpret medical imaging.

Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects

Researchers in Department of Physiology, Anatomy and Genetics have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes.